• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Extended antithrombotic therapy for secondary prevention of cardiovascular events: A tool for pharmacists.

作者信息

Rustad Kari, Tangedal Kirsten, Tri Samantha, Semchuk William

机构信息

Department of Pharmacy Services, Saskatchewan Health Authority, Regina, SK.

出版信息

Can Pharm J (Ott). 2021 Sep 21;155(1):12-17. doi: 10.1177/17151635211045973. eCollection 2022 Jan-Feb.

DOI:10.1177/17151635211045973
PMID:35035637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8756364/
Abstract
摘要

相似文献

1
Extended antithrombotic therapy for secondary prevention of cardiovascular events: A tool for pharmacists.心血管事件二级预防的延长抗血栓治疗：药师的工具
Can Pharm J (Ott). 2021 Sep 21;155(1):12-17. doi: 10.1177/17151635211045973. eCollection 2022 Jan-Feb.
2
Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis.终末期肾病行慢性血液透析患者的心血管事件一级和二级预防用抗血栓药物。
Atherosclerosis. 2020 Apr;298:1-6. doi: 10.1016/j.atherosclerosis.2020.02.011. Epub 2020 Feb 16.
3
Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.外周动脉疾病的抗血栓治疗：抗血栓治疗与血栓预防，第 9 版：美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e669S-e690S. doi: 10.1378/chest.11-2307.
4
Use of antithrombotic therapy for secondary prevention in patients with stable atherosclerotic cardiovascular disease: Insights from the COordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with CardioVascular Disease (CONNECT-CVD) study.抗栓治疗在稳定型动脉粥样硬化性心血管疾病患者二级预防中的应用：来自协调国家网络，以鼓励心血管病医生参与心血管疾病患者抗栓治疗（CONNECT-CVD）研究的见解。
Int J Clin Pract. 2021 Oct;75(10):e14597. doi: 10.1111/ijcp.14597. Epub 2021 Jul 17.
5
Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease.应用当代抗栓治疗预防慢性动脉粥样硬化性心血管疾病。
Am Heart J. 2019 Dec;218:100-109. doi: 10.1016/j.ahj.2019.09.006. Epub 2019 Oct 23.
6
Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.老年护理机构中房颤患者抗栓治疗的居家药物管理评估：卒中与出血风险评估
J Clin Pharm Ther. 2016 Jun;41(3):279-84. doi: 10.1111/jcpt.12385. Epub 2016 Apr 7.
7
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.抗血栓治疗在冠状动脉疾病和糖尿病患者中的应用：降低动脉粥样硬化性心血管疾病风险。
Circulation. 2020 Dec;142(22):2172-2188. doi: 10.1161/CIRCULATIONAHA.120.045465. Epub 2020 Nov 30.
8
Selecting antithrombotic therapy for stroke prevention in atrial fibrillation: Health professionals' feedback on a decision support tool.心房颤动卒中预防的抗栓治疗选择：决策支持工具的卫生专业人员反馈。
Health Informatics J. 2018 Sep;24(3):309-322. doi: 10.1177/1460458216675498. Epub 2016 Nov 15.
9
Updated antithrombotic strategies to reduce the burden of cardiovascular recurrences in patients with chronic coronary syndrome.更新抗栓策略以降低慢性冠状动脉综合征患者心血管复发的负担。
Biomed Pharmacother. 2021 Aug;140:111783. doi: 10.1016/j.biopha.2021.111783. Epub 2021 Jun 5.
10
Use of evidence-based therapy for the prevention of cardiovascular events among older people.老年人中基于证据的治疗方法在预防心血管事件中的应用。
Eval Health Prof. 2010 Sep;33(3):276-301. doi: 10.1177/0163278710374854.

本文引用的文献

1
Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?双联抗血小板或双联抗栓治疗用于稳定型冠心病高危患者的二级预防？
Thromb Haemost. 2019 Oct;119(10):1583-1589. doi: 10.1055/s-0039-1679903. Epub 2019 Mar 5.
2
Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease.双重通路抑制在慢性心血管疾病中的协同作用。
Circ Res. 2019 Feb;124(3):416-425. doi: 10.1161/CIRCRESAHA.118.313141.
3
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.2018 年加拿大心血管学会/加拿大介入心脏病学会抗血小板治疗应用指南重点更新
Can J Cardiol. 2018 Mar;34(3):214-233. doi: 10.1016/j.cjca.2017.12.012. Epub 2017 Dec 19.
4
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.利伐沙班联合或不联合阿司匹林治疗稳定的外周动脉或颈动脉疾病患者：一项国际、随机、双盲、安慰剂对照试验。
Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10.
5
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.利伐沙班联合或不联合阿司匹林用于稳定型心血管疾病。
N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.
6
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons.美国心脏病学会适当使用标准制定专家组、美国胸外科学会、美国心脏协会、美国超声心动学会、美国核医学学会、心血管血管造影和介入学会、心血管计算机断层扫描学会和胸外科医师学会 2016 年急性冠状动脉综合征患者冠状动脉血运重建的适当使用标准
J Am Coll Cardiol. 2017 Feb 7;69(5):570-591. doi: 10.1016/j.jacc.2016.10.034. Epub 2016 Dec 21.
7
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial.替格瑞洛用于主要不良心血管事件二级预防的长期耐受性：PEGASUS-TIMI 54 试验的二次分析。
JAMA Cardiol. 2016 Jul 1;1(4):425-32. doi: 10.1001/jamacardio.2016.1017.
8
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016美国心脏病学会/美国心脏协会关于冠状动脉疾病患者双联抗血小板治疗持续时间的指南聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115. doi: 10.1016/j.jacc.2016.03.513. Epub 2016 Mar 29.
9
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.既往心肌梗死患者停用 P2Y12 抑制剂后时间与替格瑞洛缺血风险和疗效的关系：来自 PEGASUS-TIMI 54 的见解。
Eur Heart J. 2016 Apr 7;37(14):1133-42. doi: 10.1093/eurheartj/ehv531. Epub 2015 Oct 21.
10
Long-term use of ticagrelor in patients with prior myocardial infarction.既往心肌梗死患者中长期使用替格瑞洛。
N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.